Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
158 participants
OBSERVATIONAL
2018-02-21
2024-08-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Early Infant Diet on Growth and Development
NCT00616395
New Infant Formula Supports Adequate Growth in Healthy Infants
NCT03614468
Nutrition of Premature Infants With Human Breastmilk Fortifier
NCT03191617
Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers
NCT05049655
A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure
NCT03563391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast Fed
Exclusively breastfed for first 3 months of life
No interventions assigned to this group
Milk-based formula fed
Exclusively on Similac Advance Formula for at least 1 month prior to visit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For formula feeders, exclusively on Similac Advance Formula for at least 1 month prior to visit
* Age 2.5-3.5 months
Exclusion Criteria
* Infants born to mother with medications during pregnancy known to influence fetal growth.
* Infants born to smoking, alcohol drinking or drug use mothers during pregnancy.
* Preterm
2 Months
3 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arkansas Children's Hospital Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aline Andres, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
Arkansas Children's Nutrition Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Nutrition Center
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
217562
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.